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Abstract
Fronto-striatal circuitry involving the orbitofrontal cortex has been identiﬁed as mediating successful reversal of stimulus-
outcome contingencies. The region of the striatum that most contributes to reversal learning remains unclear, with studies
in primates implicating both caudate nucleus and putamen. We trained four marmosets on a touchscreen-based serial
reversal task and implanted each with cannulae targeting both putamen and caudate bilaterally. This allowed reversible
inactivation of the two areas within the same monkeys, but across separate sessions, to directly investigate their respective
contributions to reversal performance. Behavioral sensitivity to the GABAA agonist muscimol varied across subjects and
between brain regions, so each marmoset received a range of doses. Intermediate doses of intra-putamen muscimol
selectively impaired reversal performance, leaving the baseline discrimination phase unchanged. There was no effect of
low doses and high doses were generally disruptive. By contrast, low doses of intra-caudate muscimol improved reversal
performance, while high doses impaired both reversal and baseline discrimination performance. These data provide
evidence for a speciﬁc role of the putamen in serial reversal learning, which may reﬂect the more habitual nature of
repeated reversals using the same stimulus pair.
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Introduction
Cognitive ﬂexibility, deﬁned as the ability of an organism to
adapt its thinking or behavior to changing circumstances
(Eslinger and Grattan 1993), is a key part of efﬁcient executive
function (Dajani and Uddin 2015). Greater cognitive ﬂexibility is
generally advantageous, particularly in dynamic environments,
and in humans has been linked to superior functioning across
multiple domains, including social ability (Bonino and Cattelino
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1999) and emotion regulation (Hendricks and Buchanan 2016).
Conversely, reduced cognitive ﬂexibility is associated with vari-
ous neuropsychiatric disorders including Obsessive Compulsive
Disorder (OCD; Remijnse et al. 2005), addiction (Ersche et al.
2008; Izquierdo and Jentsch 2012), depression (Murphy et al.
2003; Robinson et al. 2012), and schizophrenia (Floresco et al.
2009; Leeson et al. 2009), as well as neurodevelopmental disor-
ders such as autism spectrum disorder (Cruz et al. 2013).
Such is the importance of cognitive ﬂexibility that it has
been the subject of intensive research over the years, using a
range of different paradigms (Kehagia et al. 2010; Cools 2015).
Reversal learning is one such paradigm that has been well-
validated (Izquierdo and Jentsch 2012). In a typical protocol,
subjects must learn to discriminate between one of two stimuli
to gain reward, only for the stimulus/action-outcome associa-
tions to then be reversed. The relative simplicity of the task has
meant it has been possible to adapt the procedure to accommo-
date performance in a wide variety of species (Izquierdo et al.
2016), thus allowing considerable translational potential
(Oikonomidis et al. 2016; Robbins 2017).
The orbitofrontal cortex (OFC) is widely accepted to be critical
for reversal learning in rodents (Hamilton and Brigman 2015)
and marmosets (Dias et al. 1996; Clarke et al. 2008; Oikonomidis
et al. 2016). Although a speciﬁc role of the macaque OFC in rever-
sal learning has been refuted (Rudebeck et al. 2013), a more pos-
terolateral region has since been implicated (Chau et al. 2015).
The striatum, which receives strong projections from the OFC
(Haber et al. 1995; Roberts et al. 2007; Schilman et al. 2008;
Heilbronner et al. 2016), also plays a major role. Thus, lesions or
inactivations of the caudate nucleus (Divac et al. 1967) and
nucleus accumbens (Stern and Passingham 1995) in rhesus mon-
keys and marmosets (Clarke et al. 2008), and the dorsomedial
(Kirkby 1969; Ragozzino et al. 2002; Castañé et al. 2010) and ven-
tral striatum (Annett et al. 1989; Ferry et al. 2000, but see
Castañé et al. 2010) of the rat, have all been shown to induce
reversal learning deﬁcits. In addition, dopaminergic depletion
within the medial caudate impairs reversal learning in marmo-
sets (Clarke et al. 2011) as does a D2/3 receptor agonist infused
into rat nucleus accumbens (Haluk and Floresco 2009).
Despite this consensus for a role of the OFC and medial/ven-
tral striatum in reversal learning, a recent correlative study has
advanced an alternative perspective implicating dopamine-
dependent processes of the putamen interacting with serotonin-
dependent OFC substrates in vervet monkeys (Groman et al.
2013). This combination of OFC serotonin and striatal dopamine,
although broadly consistent with neurochemical ﬁndings in
marmosets (Clarke et al. 2004, 2005, 2007, 2011), differs by virtue
of it implicating the putamen rather than the caudate as the crit-
ical striatal locus.
Since a causal role for the putamen has been little studied
with respect to reversal learning, the aim of the present inves-
tigation was to clarify the respective contributions of the pri-
mate anterior putamen and medial caudate. Marmosets were
trained on a serial reversal learning paradigm (Rygula et al.
2010), the design of which supported the use of repeated, acute
manipulations. The task comprised a daily baseline discrimi-
nation phase in which responding to one of two highly familiar
stimuli was paired with reward and responding to the other
produced negative feedback. This was followed by a phase in
which the action-outcome contingencies were reversed. These
reversed contingencies then formed the basis of the baseline
discrimination phase on the next day, immediately followed
by another reversal. The two phases within a daily session
made it possible to isolate impairments speciﬁc to reversal
learning from more general deﬁcits affecting discrimination
performance in both phases of the task. Marmosets were
implanted with indwelling cerebral cannulae targeting the
medial caudate and anterior putamen (as deﬁned in Groman
et al. 2013). These regions were then independently and revers-
ibly inactivated using an individually tailored range of doses of
the GABAA agonist, muscimol.
Materials and Methods
Subjects and Housing
Four experimentally naïve marmosets (Callithrix jacchus; all
male), bred on site at the University of Cambridge Marmoset
Breeding Colony, were housed in pairs (male-female or male-
male, males being vasectomized) in custom-made housing.
Rooms were maintained at 22 ± 1 °C and 50 ± 1% relative
humidity and were gradually illuminated from 7:00 to 7:30 am
and dimmed from 7:00 to 7:30 pm, following a 12-h light/dark
cycle with dawn and dusk. Marmosets received a nutritionally
complete diet, which consisted of sandwiches, fruit, and rusk
at the weekend, and a restricted but calorically equivalent diet
of pellets and fruits or vegetables during the week. From
Monday to Friday, access to water was restricted for 22 h out of
every 24, with ad libitum access for the remaining two hours
after behavioral testing, and ad libitum access over the week-
end. The housing contained a range of environmental enrich-
ment aids including ropes and rope ladders, and marmosets
were given occasional treats after testing. Marmosets were
weighed on a weekly basis and their welfare monitored by
members of the research and husbandry teams. All procedures
were carried out in accordance with the UK Animals (Scientiﬁc
Procedures) Act 1986 as amended in 2012, under project
licenses 80/2225 and 70/7618. In addition, the University of
Cambridge Animal Welfare and Ethical Review Board provided
ethical approval of the project license and its amendments, as
well as individual studies and procedures via delegation of
authorization to the Named Animal Care and Welfare Ofﬁcer
(NACWO) for individual study plans.
Behavioral Testing Apparatus
Marmosets were tested once daily on Monday to Friday and
given time off at the weekend. All marmosets were ﬁrst trained
to enter a Perspex carrying box in which they were transported
to a behavioral testing apparatus within a darkened room. The
apparatus was comprised of a custom-made sound-attenuated
box containing a touch-sensitive computer monitor (“touchsc-
reen”; NEX121 TFT LCD Monitor; Nexio). The carrying box was
placed within the apparatus, with one side removed to enable
access to the touchscreen through a vertical array of metal
bars. A centrally placed licking spout allowed the delivery of
cooled banana-ﬂavored milk (made with Nesquik powder;
Nestlé) as the positive reinforcer. Licking was detected by the
interruption of an infrared photobeam situated at the mouth of
the licking spout. A speaker at the back of the chamber played
the sounds used in the experiments: a birdsong recording,
which acted as a cue to collect reward, or a ~100 dB brief (0.3 s)
auditory stimulus used to signal incorrect choices. Stimulus
presentation upon the touchscreen, the speaker, and the rein-
forcer pumps was controlled by modules within the
MonkeyCantab program (v9.3–11.2, R.N. Cardinal) developed
from MonkeyCantab (Weed et al. 1999; originally designed by
Robbins and Roberts) and using the Whisker control system
(Cardinal and Aitken 2010) via an operant chamber interface
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(Biotronix). All experiments were monitored in real-time by
video cameras mounted to the roof of the touchscreen cham-
ber. A schematic of the testing apparatus and still images from
a behaving animal recorded from a mounted video camera are
shown in Figures 1C–D.
Preliminary Behavioral Training
Marmosets were acclimatized to the carrying box, touchscreen
chamber, and banana-ﬂavored milk reinforcer. They were then
gradually trained, in a manner ﬁrst described in Roberts et al.
(1988), to respond on the touchscreen for reward. Marmosets
were then moved to a “lick contingent” condition where, upon
touching a stimulus presented on the touchscreen, “birdsong”
would be played to cue reward availability, and reward delivery
would begin when the marmoset began to lick at the licking
spout, as detected by the interruption of the infrared photo-
beam. All sessions were twenty minutes long.
Training on Serial Reversal Learning Paradigm
Subjects were given two training visual discriminations in the
“Pre-training” phase and then moved to the main discrimina-
tive set (Fig. 1) for initial between-session reversal training.
Figure 1. Schematic of task and experimental design. A. Timeline of experimental protocol. Naïve marmosets were taught to respond on the touchscreen “Pre-train-
ing”, and then to perform the serial reversal learning task “Reversal training”. Once marmosets were exhibiting stable reversal performance they underwent cannula-
tion of the medial caudate and anterior putamen. Post-surgery, marmosets received intra-striatal infusions of the GABAA agonist muscimol or saline control
infusions on test days. B. Schema illustrating stimulus-outcome contingencies across two consecutive days. After reaching a behavioral criterion of six correct
responses within seven trials in the baseline discrimination phase of a session, the stimulus-outcome contingencies were reversed, and the marmoset then had to
achieve six correct responses within six trials to pass the reversal phase of the session. The next day, the stimulus-outcome contingency of the baseline discrimina-
tion phase was the same as that in the reversal phase of the previous day. C. Diagram illustrating the position of the marmosets within the behavioral testing appara-
tus and carrying box in relation to the touchscreen, houselights and video cameras. D. Photographs of a marmoset performing the serial reversal learning task,
showing counter-clockwise from top left: the marmoset touching a stimulus, punishment darkness following an incorrect response, collection of banana-ﬂavored
milk reward following a correct response and an inter-trial interval.
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Reward delivery and inter-trial interval (ITI) remained the same
as in the ﬁnal stages of preliminary behavioral training, with
5 s of banana-ﬂavored milk delivered lick-contingently with a
“birdsong” cue upon response to the correct stimulus, and an
auditory cue (0.3 s long at a volume of ~100 dB) in addition to
5 s of darkness when marmosets made an incorrect choice. The
selected visual stimulus remained on the screen during the 5 s
of either reward delivery or darkness. The daily testing session
terminated after a subject reached the criterion of six consecu-
tive correct responses, or failing that, after 20min had elapsed.
Upon reaching criterion, stimulus-reward contingencies were
reversed in the subsequent session, such that the previously
correct stimulus became incorrect and the previously incorrect
stimulus became correct. Marmosets were tested on the new
stimulus-reward contingencies until they re-gained criterion.
The response-outcome contingencies were again reversed for
the subsequent session, and marmosets continued to be tested
on these “between-session” reversals until they could consis-
tently, upon receiving reversed response-outcome contingen-
cies, learn the reversed contingencies within the session—a
“same-day pass”. Marmosets progressed to “within-session”
reversals when they had achieved 10 same-day passes, though
these did not need to be consecutive.
Within-Session Serial Reversal Learning Paradigm
Within-session reversals comprised a baseline discrimination
phase where response-outcome contingencies were the same
as those at the end of the previous day, and a reversal phase,
where they were inverted. Upon six correct responses within
seven consecutive trials (baseline discrimination phase), the
response-outcome contingencies were reversed (reversal
phase). There were no environmental signals that cued the
transition between phases other than the change in response-
outcome contingencies. The testing session terminated after
either marmosets reached the criterion of six consecutive cor-
rect responses on the reversal phase, or failing that, 20min had
elapsed. In the event that a subject did not pass the baseline
discrimination phase of a session, the response-outcome con-
tingencies at the beginning of the baseline discrimination
phase of the next session would remain the same as those of
the previous day’s failed baseline discrimination phase. If a
subject did not pass the reversal phase of the session, the
response-outcome contingencies of the following day’s base-
line discrimination phase were the same as those in the failed
reversal phase. Once a marmoset had exhibited stable reversal
performance, as deﬁned by the successful completion of ten
within-session reversals, they underwent cannulation surgery
and, after recovery, received intra-striatal infusions of saline
vehicle or the GABAA agonist muscimol to inactivate the ante-
rior putamen or medial caudate on test serial reversal sessions
interspersed between non-infusion sessions.
Cannulation Surgery
Marmosets were pre-medicated using 0.1mL (100mg/mL) of the
anesthetic ketamine hydrochloride i.m. (Vetelar; Amersham
Biosciences and Upjohn) and 0.03mL of 50mg/mL of the analge-
sic carprofen s.c. (Carprieve; Pﬁzer). They were intubated and
anesthesia maintained by administration of 2.0%–2.5% isoﬂur-
ane in 0.3 L/min O2, and then placed upon a heat mat positioned
within a stereotaxic frame modiﬁed for the marmoset (David
Kopf). Pulse rate, O2 saturation, breathing rate, and CO2 satura-
tion were all monitored by pulse oximetry and capnography
(Microcap Handheld Capnograph; Oridion Capnography), and
core body temperature was monitored by a rectal thermometer
(MicroTherma 2T digital thermometer; ThermoWorks). The per-
centage of isoﬂurane in the isoﬂurane/O2 mixture and the heat
mat temperature were modulated during surgery in response to
changes in vital signs, 1.0mL of warmed saline was given s.c.
every 90min to prevent dehydration, and the hind legs and body
were turned every hour to stimulate blood ﬂow.
Indwelling guide cannulae (Plastics One) were implanted to
target the ventromedial caudate and putamen; the double
guide cannulae (26-gauge, 2.4mm c/c) were custom-made so
that one guide targeted the ventromedial caudate (8mm in
length) and the other, the putamen (9mm in length) at coordi-
nates of anteroposterior (AP) + 11, lateromedial (LM) ± 2.55,
ventral (V) + 11.5 and AP + 11, LM ± 4.95, V + 10.5, respectively.
AP Coordinates were adjusted where necessary in situ accord-
ing to a prefrontal cortical depth procedure described in
Roberts et al. (2007). Cannulae were ﬁxed in place with the aid
of an array of steel skull screws (Plastics One) and the applica-
tion of an adhesive (Super-Bond C&B; Sun Medical Co.) across
the skull surface, as well as the application of dental acrylic
(Paladur, Kulzer, Mitsui Chemicals Group) to the surrounds of
the guide cannulae. Wire stylets were inserted to occlude the
cannulae and protective caps screwed on top. Postoperatively,
and when fully recovered (usually within 3-4 h) all monkeys
were returned to their home cage and then received 0.1mL of
the analgesic agent meloxicam (1.5mg/mL oral suspension;
Boehringer Ingelheim) for 3 days, after which they received a
further “rest” period (weekend food, ad libitum water, and no
behavioral testing) of at least 1 week. Cannulae were cleaned
every week (and caps and cannula occluders changed) to
ensure the cannulae remained patent and the implant site
free from infection.
Post-Mortem Assessment of Cannula Placement
Animals were pre-medicated with 0.1mL i.m. of ketamine
hydrochloride (Vetalar; 0.05mL of a 100-mg solution, i.m.;
Amersham Biosciences and Upjohn) before being euthanized
with 1.0mL i.v. of pentobarbital sodium (Dolethal; 200mg/mL
solution; Merial Animal Health). Animals were then perfused
transcardially with 500mL 0.1M PBS solution, followed by
500mL of 4% paraformaldehyde ﬁxative solution. The brain
was removed and left in the 4% paraformaldehyde ﬁxative
solution overnight before being transferred to 30% sucrose–PBS
solution for at least 48 h. Brains were then sectioned on a freez-
ing microtome (coronal sections; 60 μm), mounted on gelatin-
subbed slides, and stained with cresyl fast violet. The sections
were viewed under a Leitz DMRD microscope (Leica
Microsystems). The cannula locations for each animal were
schematized onto drawings of standard marmoset brain coro-
nal sections, and composite diagrams were then made to illus-
trate the extent of overlap between animals (Fig. 2). A
histological section is also presented to illustrate cannulae pla-
cements in both the medial caudate and anterior putamen in
an individual subject.
Intra-cerebral Drug Infusion Protocol
Intra-cerebral drug infusions were conducted according to stan-
dardized laboratory protocols as previously described (Clarke
et al. 2015), under sterile conditions. The marmoset was gently
restrained by an assistant, the caps and cannula occluders
were removed from the guide cannulae, and the site was
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cleaned with 70% isopropyl alcohol. An injector (Plastics One)
connected to a 10 μL Hamilton syringe in a syringe pump was
inserted into the guide cannula so as to protrude at least
0.5mm from the tip of the guide, and 0.5 μL of saline or
0.03–0.3 μg muscimol in 0.5 μL saline was infused bilaterally into
either medial caudate or putamen at a rate of 0.25 μL/min. The
consensus from previous studies using ﬂuorescent-tagged
(Allen et al. 2008) or radio-labeled (Sperber et al. 1989; Krupa
and Thompson 1997; Martin and Ghez 1999) muscimol and/or
glucose metabolism (Martin and Ghez 1999) is an effective
radius of ~1.5mm for the inactivating effects of muscimol at
doses, volumes, and infusion rates similar to those used here.
Thus, with injector tips located 2.6mm apart, we do not expect
infusions in one striatal region to affect the other area directly.
Following the infusion, the injector was left in place for a fur-
ther minute to allow the drug to diffuse before injector removal.
Fresh, sterile occluders and caps were replaced, and the marmo-
set was returned to its home cage for 40min before the behav-
ioral testing session commenced. The number of infusions
received per animal (putamen, caudate) was as follows: Subject
1 (2, 2); Subject 2 (4, 2); Subject 3 (6, 3); Subject 4 (4, 3).
Determination of Muscimol Dose Range and Intra-
cerebral Infusion Regimen
Marmosets completed a sequence of muscimol infusions into
the anterior putamen before receiving a similar sequence into
the medial caudate nucleus. Individuals showed differential
behavioral sensitivity to speciﬁc doses of intra-striatal musci-
mol, but common patterns of ordinal dose-dependent effects
were apparent after muscimol infusions in both putamen and
caudate. We adopted a stringent procedure for determining the
individual dose response ranges (see Table 1). All animals ini-
tially received an infusion of 0.3 μg into the putamen. A lower
dose of 0.1 μg was subsequently administered either when fail-
ure to respond resulted in premature disengagement from the
task (thus, precluding accurate measures of reversal learning
performance) or if an animal exhibited generalized deﬁcits
across both task phases. Depending on the response to this
dose, further doses were administered either above (0.18 μg) or
below 0.1 μg (0.03 and 0.06 μg) in order to deﬁne the graded
nature and selectivity of any dose-related behavioral effects.
Our primary interest was to determine the dose at which each
animal showed behavioral effects in the reversal phase only.
For each subject the highest dose that produced a selective
behavioral effect on reversal in the putamen was then chosen
to be the ﬁrst dose infused into the medial caudate nucleus
(see Table 2). In cases where the initial dose produced either no
impairment, premature response disengagement, or general-
ized disruption of performance across both task phases, a high-
er or lower dose was subsequently infused accordingly.
Whereas the dose-dependent effects of intra-putamen musci-
mol were described by three doses (low, intermediate, and
high), in caudate, animals displayed only two distinct effects;
thus the dosing categories for caudate infusions are only low
and high. Note that the low and high doses for caudate are not
necessarily the same absolute doses as those producing low
and high-dose effects in the putamen. The relationships
between doses are described in Tables 1 and 2. The ﬁrst animal
to receive a putamen infusion (Subject 1) showed the selective
reversal effect with the initial 0.3 μg dose, which was then
infused into the caudate. Unfortunately, the implant of this
animal was then irreparably damaged, and we were unable to
establish any further dose-dependent effects in either area.
Control saline infusions were interpolated randomly within
the infusion series for the putamen and caudate nucleus.
Marmosets received one or two infusions per week depending
upon the stability of their performance. Infusions were admin-
istered at least 48 h apart from one another.
Behavioral Measures
The main behavioral measures were the numbers of errors and
trials in the baseline discrimination and reversal phases of the
task on the infusion session and the preceding control session.
To better understand the nature of any differences in post-
infusion performance we also assessed “strategy” in terms of
response types following rewarded vs. unrewarded trials (e.g.,
win-stay/lose-shift) and plotted errors against trials to produce
learning curves for the reversal phase. Latencies were assessed
to determine whether intra-striatal muscimol affected motor
responses following rewarded and unrewarded responses.
Statistical Approach and Data Analysis
Intra-striatal muscimol inactivation data were analyzed using
mixed-model analyses of variance (ANOVAs), which were pro-
grammed using the statistical computing language R, version
3.3.1 with the Mac GUI R.app version 1.68. Linear mixed-effects
modeling was achieved with the lme4 package (Bates et al. 2014),
with statistical tests applied with the lmerTest package
(Kuznetsova et al. 2016) using Type III sums of squares with the
Satterthwaite approximation for degrees of freedom. Interactions
and other effects were further investigated using general linear
Figure 2. Schematics showing the intra-cerebral cannulae placements in the
medial caudate and putamen for each subject, in AP planes 10.6 and 11.4. In the
representative histological section (taken from Subject 3), black arrows show
the placement of the tip of the infusion cannulae in the medial caudate, and
white arrows the placement of the tip of the infusion cannulae in the anterior
putamen.
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hypothesis tests (glht in multcomp package; Hothorn 2017) on
the estimated marginal means with the Holm adjustment for
multiple comparisons.
For the purposes of statistical analysis we computed differ-
ence scores for errors made or trials completed on the infusion
day minus the immediately preceding control session when no
infusion was given (non-infusion day). There was marked indi-
vidual variation in normal non-infusion performance, and the
difference score reduced the contribution of this variation to
the model by allowing each animal to act as its own control.
For the independent variable of muscimol dose in the putamen,
we deﬁned three levels, low, intermediate and high. The high
dose was that producing either generalized behavioral disrup-
tion involving impairment in baseline discrimination as well as
reversal or premature task disengagement during the reversal.
The intermediate dose was the highest dose producing a selec-
tive reversal effect, the low dose having weaker or no effect.
A similar categorization of doses was applied to the caudate
data, with high-dose intra-caudate muscimol producing a gen-
eralized deﬁcit across both task phases or premature response
disengagement and low dose producing no impairments. There
was no intermediate dose effect in the caudate.
ANOVA was performed for the putamen and caudate inacti-
vations separately. Fixed factors chosen for the initial ANOVA
included the session phase, i.e., baseline discrimination or
reversal (“Phase”), and the dose of muscimol and saline
(“Dose”), while subject was modeled as a random factor. The
high-dose was not included in the analysis for the putamen
because of the premature task disengagement in some animals,
which meant that error scores were artiﬁcially low. Post hoc
analyses were performed using separate independent mixed-
model ANOVAs on the baseline discrimination and reversal
phases. Further pairwise comparisons were made between
individual data points based on the estimated marginal means
with the Bonferroni–Holm adjustment.
Given the previously demonstrated perseverative nature of
the reversal impairment following lesions of the caudate
nucleus in marmosets (Clarke et al. 2008), muscimol-related
selective reversal impairments were assessed for evidence of
perseveration. This was achieved using two methods. First,
counts of errors committed prior to the ﬁrst correct post-
reversal response were compared between the infusion day and
the preceding non-infusion control session for impairing musci-
mol doses and saline. A mixed-model ANOVA of these data was
followed by post hoc analysis of any effects by general linear
hypothesis testing. Because some animals committed correct
responses spuriously even in the ﬁrst reversal trial, we addition-
ally used signal detection theory to classify whether responding
on the previously correct stimulus during the ﬁrst six trials after
reversal was above, at, or below chance (see Clarke et al. 2004,
2005 for details of this analysis method). We chose to only ana-
lyze the ﬁrst six trials, as this was the minimum number of
trials required to pass the reversal criterion and all animals
completed at least this many trials if they reached the reversal
phase. We then used Fisher’s Exact Test to assess whether the
proportion of animals that showed a perseverative response
proﬁle after muscimol infusion-induced impairment was higher
than was observed after saline infusions.
Table 1. Doses of muscimol infused into the putamen. All animals initially received an infusion of 0.3 μg into the putamen (dose denoted by †).
Animals that were grossly impaired by this dose were then given lower doses in an iterative fashion to determine the dose that produced a
selective reversal impairment on the error difference score, as compared to saline. Dosing categories are denoted by labels as follows: Lowp =
putamen low, Intp = putamen intermediate, Highp = putamen high, H+p = a high putamen dose that produced general impairment in Subject 2.
Gray shading reﬂects a signiﬁcant impairment. A superscript “F” indicates failure to reach behavioral criterion. The intermediate doses from
putamen infusions were used as the ﬁrst dose in caudate infusions.
Baseline discrimination Reversal
Subject 0.03 μg 0.06 μg 0.1 μg 0.18 μg 0.3 μg† 0.03 μg 0.06 μg 0.1 μg 0.18 μg 0.3 μg†
1 Intp Intp
2 Lowp Intp Highp H+p
F Lowp Intp Highp
F
3 Lowp Intp Highp Lowp Intp
F Highp
F
4 Lowp Intp Highp Lowp Intp
F Highp
F
Table 2. Doses of muscimol infused into the caudate. All animals initially received an infusion of the muscimol dose that produced a selective
reversal effect in the putamen (dose denoted by underline). This initial dose produced either a selective reversal improvement (superscript
“I”, Subject 1) or impairment (gray shading, Subjects 2–4) across both task phases, as measured against saline performance. Whilst subjects
varied in their behavioral sensitivity to speciﬁc doses of muscimol, overall, lower caudate doses (Lowc) produced a selective reversal improve-
ment whilst higher caudate doses (Highc) caused baseline discrimination impairments. A superscript “F” indicates failure to reach behavioral
criterion. Subject 1 received only a single dose, due to implant damage sustained after the ﬁrst caudate infusion.
Baseline discrimination Reversal
Subject 0.03 μg 0.06 μg 0.1 μg 0.18 μg 0.3 μg 0.03 μg 0.06 μg 0.1 μg 0.18 μg 0.3 μg
1 Lowc Lowc
I
2 Highc Highc
3 Lowc Highc Lowc
I Highc
4 Lowc Highc Lowc
I Highc
F
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Impairments and improvements were further investigated
to determine whether changes in performance following mus-
cimol infusions were due to changes in responding after
rewarding or non-rewarding feedback. The probability of a
“win-stay” response (P(Stay | Win)) is calculated by dividing the
number of times an animal selects the correct stimulus after
having just received a reward for responding on the same stim-
ulus by the total number of correct responses. The probability
of a “lose-shift” (P(Shift | Loss)) response is determined by divid-
ing the number of times the alternative stimulus is selected
after an error by the total number of errors. The optimum strat-
egy is to maximize both win-stay and lose-shift responses. The
impact of intra-striatal muscimol on strategy usage was exam-
ined using separate repeated measures (rm)ANOVAs (aov_car
from afex package; Singmann et al. 2018) of win-stay and lose-
shift probabilities with the within-subject factor of Day (infu-
sion day vs. preceding non-infusion day).
Median response latencies were calculated for correct and
incorrect responses and a difference score taken between infu-
sion sessions and non-infusion control sessions. A three-way
mixed-model ANOVA with task phase, response outcome, and
dose was followed by post hoc analyses, as described above.
Results
Cannulation Placements
The tips of the infusion cannulae could be visualized in the his-
tological sections of each animal as illustrated in the photomi-
crograph of an exemplar animal in Figure 2. In all cases, the
placements were located in the medial caudate and anterior
putamen with a maximum 0.8mm variation in the location of
putamen placements between animals and the same variation
in location of caudate placements between animals (see sche-
matics in Fig. 2). There was little visible sign of any non-speciﬁc
tissue damage around the cannula tips (see representative sec-
tion in Fig. 2).
Performance on the Serial Reversal Task Remained
Stable Across Sessions
To determine whether implantation of cannulae or repeated
infusions affected behavioral performance, we used rmANOVAs
to compare average performance (mean of four sessions, two of
each stimulus-outcome conﬁguration) at three time points:
prior to cannula implantation, after cannula implantation but
before the ﬁrst infusion, and at the end of the study. There was
no effect of time point on either errors (F(2,6) = 1.15, P = 0.38) or
trials (F(2,6) = 1.81, P = 0.24), nor were there interactions
between time point and task phase (errors: F<1; trials: F<1).
Only task phase signiﬁcantly impacted performance in any way
(errors: F(1,3) = 35.1, P = 0.0096; trials: F(1,3) = 29.4, P = 0.012).
Similarly, since all animals experienced intra-putamen infu-
sions prior to intra-caudate infusions, we compared average
performance on control sessions preceding infusions within
each striatal region to determine whether variation in perfor-
mance over time could account for any differences in the
behavioral responses to muscimol between striatal regions.
There were no striatal region-related differences in the number
of errors on preceding sessions for either the reversal phase
(paired t-tests of putamen vs. caudate; putamen = 17.25 ± 2.50
errors (44.4 ± 5.54 trials); caudate = 14.88 ± 2.14 errors (38.7 ±
4.51 trials); F<1 (F<1)) or for the baseline discrimination (puta-
men = 3.69 ± 1.12, errors (11.6 ± 2.16 trials); caudate = 6.21 ± 0.50
errors (17.6 ± 1.12 trials); F<1 (F<1)).
Intra-Putamen Muscimol Infusions Produced Dose-
Dependent Selective Impairments in Reversal Learning
Intra-putamen muscimol infusions induced graded, dose-
dependent deﬁcits across the two phases of the task, the range
of doses inducing these graded effects varying across individuals
(Fig. 3A). Although behavioral sensitivity to speciﬁc doses varied
between marmosets, the consistent ordinal pattern of effects
allowed us to classify doses as low, intermediate, or high.
Neither the low nor the intermediate dose had any effect on the
baseline discrimination phase. However, all four animals exhib-
ited selective deﬁcits at the reversal phase following intermedi-
ate doses. At high doses, all animals displayed a generalized
deﬁcit across baseline discrimination and reversal phases or
stopped responding during the reversal phase.
Figure 3. Effects of intra-putamen (A) and intra-caudate (B) administration of
muscimol and saline on the error difference score (number of errors in the infu-
sion session minus errors from the preceding control session) in the baseline
discrimination and reversal phases of the task. The bars in each plot represent
the mean for saline and varying doses of intra-striatal muscimol (Sal = saline,
Low = lower dose, Int = intermediate dose, High = higher dose, with subscripts
“p” for “putamen” and “c” for “caudate”). Data for individual subjects are
denoted by the symbols deﬁned in the tables below each plot, where speciﬁc
doses are also tabulated. †indicates that Subject 4’s high-dose data was not
included in the analysis of reversal performance (see Results). * = P < 0.05 in
post hoc tests.
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A mixed-model ANOVA conﬁrmed a selective effect on
errors in reversal following intermediate doses, as shown by a
signiﬁcant Phase by Dose interaction (F(2,16) = 8.26; P =
0.00343). Separate analysis of the two phases revealed that
intra-putamen muscimol did not affect the baseline discrimi-
nation phase (F(2,4.95) = 1.50; P = 0.311), but did produce a sig-
niﬁcant deﬁcit in the reversal phase (F(2,8) = 7.04; P = 0.0172).
Pairwise comparisons of muscimol doses with saline showed
that only intermediate doses produced signiﬁcantly more
errors (Intermediate vs. Saline: P < 0.001, Intermediate vs. Low:
P < 0.05, Low vs. Saline P > 0.05). There were no differences in
performance across non-infusion sessions as measured by a raw
error count (Supplementary Fig. S1A). A mixed-model ANOVA
conﬁrmed an effect of reversal (F(1,13.3) = 75.2, P = 7.7 × 10−7),
but no effect of Dose (F<1) or Phase × Dose interaction (F(2,13.3)
= 1.99, P = 0.17).
The number of trials completed was not as strongly inﬂuenced
by intra-putamen muscimol infusions (Supplementary Fig. S2A).
Figure 4. Effects of intra-putamen administration of muscimol and saline on the baseline discrimination and reversal phases of the task per subject. Baseline discrim-
ination phase performance is displayed as bar graphs with the total number of responses split into correct (light shading) and incorrect trials/errors (dark shading).
Reversal phase performance is shown as a learning curve, with cumulative errors plotted against trials. F denotes the failure of a subject to pass the relevant phase at
a speciﬁc dose.
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There was a trend toward signiﬁcant interaction between Phase
and Dose (F(2,16) = 3.29, P = 0.064) on number of trials, which was
driven by a trend toward an increase in trials at the intermediate
muscimol dose (Intermediate vs. Saline: P = 0.058, Intermediate
vs. Low: P > 0.05, Low vs. Saline P > 0.05) in the reversal phase.
There were no effects of intermediate- or high-dose intra-
putamen muscimol on the number of errors preceding the ﬁrst
post-reversal correct response (Day: F<1, Dose: F(2,13.9) = 1.37,
P = 0.29; Day × Dose: F(2,13.9) = 0.48, P = 0.63). The analysis
based on signal detection theory classiﬁed three of four ani-
mals as perseverative in the ﬁrst six reversal trials after the
intermediate muscimol dose, with no animals showing persev-
eration in the preceding non-infusion sessions. The serial
nature of this task reduces the number of perseverative errors
committed upon reversal considerably, compared to non-serial
reversal learning tasks when animals are less familiar with the
concept of reversing (e.g., Clarke et al. 2004, 2008).
Analysis of response strategy following positive and negative
feedback was conducted to gain further insight into the nature of
the intermediate dose muscimol impairment (Supplementary
Fig. S3). There was a signiﬁcant decrease in the probability of
sticking to the previously selected stimulus after receiving reward
(“win-stay”) after intermediate intra-putamen muscimol as com-
pared to non-infusion performance (F(1,3) = 147.3, P = 0.0012). A
similar decrease in shifting away from the stimulus now associ-
ated with negative feedback (“lose-shift”) was present at a trend
level after intermediate muscimol doses (F(1,3) = 6.66, P = 0.082).
Individual trial-by-trial data are shown in Figure 4, which
depicts cumulative errors over trials for each subject during the
reversal phase. The gradient of the learning curve for interme-
diate intra-putamen doses of muscimol was steeper than that
of the saline curve, indicative of a higher proportion of errors.
There is little evidence of perseveration per se, as indicated by
the lack of steep increases on the y-axis.
Intra-Caudate Muscimol Infusions Produced Bi-Phasic
Effects in Reversal Learning
Muscimol infusions into the caudate, similar to the putamen,
also had graded dose effects dependent upon task phase.
Whilst high doses impaired baseline discrimination and rever-
sal, by contrast, low doses signiﬁcantly improved reversal
learning (Fig. 3B).
A mixed-model ANOVA on the error difference score con-
ﬁrmed a signiﬁcant main effect of Dose (F(2,11.4) = 16.9; P <
0.001) and a strong trend toward a Phase by Dose interaction (F
(2,10.5) = 3.60; P = 0.0643). While there was a signiﬁcant effect
of Dose in both baseline discrimination (F(2,7) = 8.95, P = 0.0118)
and reversal phases (F(2,3.32) = 49.6, P = 0.00336), pairwise com-
parisons revealed a reduction in the error difference score spe-
ciﬁcally following low-dose intra-caudate muscimol as
compared to saline (P < 0.0001) in the reversal phase. High-dose
intra-caudate muscimol, in contrast, signiﬁcantly increased
errors both in the reversal (High vs. Saline: P < 0.00005, High vs.
Low: P < 0.0001), and the baseline discrimination phase (High
vs. Saline: P < 0.001, High vs. Low: P < 0.0005). Subject 4’s failed
reversal data were excluded, because his impairment in base-
line discrimination precluded his reaching reversal criterion in
the allotted session time. There were no differences in perfor-
mance across non-infusion sessions as measured by a raw
error count (Supplementary Fig. S1B). A mixed-model ANOVA
conﬁrmed an effect of reversal (F(1,13) = 16.3, P = 0.0014), but no
effect of Dose (F<1) or Phase × Dose interaction (F<1).
Similarly, intra-caudate muscimol doses signiﬁcantly
affected the trial count (F(2,13) = 14.8, P = 0.00044) and task
phase (F(1,13) = 5.50, P = 0.036), with a trend level interaction
between Phase and Dose (F(2,13) = 2.83, P = 0.096). Dose signiﬁ-
cantly inﬂuenced the number of trials performed in both base-
line discrimination (F(2,7) = 11.7, P = 0.0059) and reversal
(F(2,6) = 6.53, P = 0.031) phases. The reduction observed in
reversal errors at low dose was reﬂected in the trial count at a
trend level (Low vs. Saline: P = 0.053), while the high dose gen-
erally impaired performance compared to saline and low-dose
muscimol during both the baseline discrimination (High vs.
Saline: P < 0.00001; High vs. Low: P < 0.00001) and in reversal
(High vs. Saline: P = 0.072; High vs. Low: P < 0.005), as it did
with errors (Supplementary Fig. S2B).
Assessment of strategy usage to understand the low-dose
muscimol reversal improvement (Supplementary Fig. S4) indicated
that there was no effect of low-dose intra-caudate muscimol on
win-stay as compared to the associated non-infusion control ses-
sions (F<1). By contrast, there was a slight but non-signiﬁcant
increase in lose-shift responding (F(1,2) = 11.2, P = 0.079).
For the high-dose intra-caudate muscimol impairment,
analysis of strategy use revealed a signiﬁcant reduction in win-
stay behavior (F(1,2) = 21.7, P = 0.043; Supplementary Fig. S5A)
but no effect on lose-shift responding in the baseline discrimi-
nation phase (F<1). For the high-dose reversal impairment
(Supplementary Fig. S5B), there was a similar but non-
signiﬁcant reduction in win-stay (F(1,2) = 2.45, P = 0.26).
Individual learning curves are plotted for muscimol infu-
sions into the caudate in Figure 5. In contrast to the steeper
learning curves observed after intermediate dose intra-
putamen infusions, shallower learning curves were evident fol-
lowing low doses of intra-caudate muscimol indicative of their
improved performance.
Assessment of Response Latencies Following Intra-
striatal Muscimol Infusions
There were no effects (P > 0.1) of any factors (muscimol dose,
task phase, or correct vs. error) on the latency difference score
(median latency on day of infusion—median latency on preced-
ing non-infusion day) in either putamen or caudate-associated
datasets.
Discussion
These results provide a new perspective on the relative roles of
the putamen and caudate in reversal learning in primates.
Intra-putamen and intra-caudate infusions of muscimol pro-
duced differential dose-dependent effects in marmosets per-
forming a serial reversal learning task. Intermediate doses of
muscimol into the putamen induced selective impairments in
the reversal phase of the task, leaving performance unchanged
in the baseline discrimination phase. At higher doses, subjects
showed more profound, non-selective deﬁcits that either
increased errors across both phases of the task or caused the
animals to disengage from the task during the reversal phase.
In contrast, relatively low doses of intra-caudate muscimol
improved reversal learning whilst a higher dose impaired base-
line discrimination performance.
Three major features of these results deserve highlighting
and provide important new insights into the differential roles
of the putamen and caudate in visual discrimination learning
and reversal. First, the anterior putamen, rather than the
medial caudate, makes a positive contribution to serial reversal
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learning, as shown by the selective impairment in reversal fol-
lowing intermediate doses of intra-putamen muscimol.
Second, the apparent opposing contribution of the medial cau-
date to serial reversal learning as shown by the improved
rather than impaired performance in reversal following rela-
tively low doses of muscimol into the medial caudate. Finally,
third, the unexpected and pronounced deﬁcits on baseline dis-
crimination produced by higher doses of muscimol into the
medial caudate, compared to the relatively inconsistent effects
on this behavior of comparable doses of muscimol infused into
the anterior putamen. In addition, it is also worth noting that
there were marked individual differences in behavioral sensitiv-
ity to muscimol both between animals and between striatal
regions within the same animal. The latter is perhaps not sur-
prising given prior evidence of marked individual differences in
the degree of GABAA receptor binding in the striatum of rats
which was shown to correlate with novelty- and amphetamine-
induced locomotion (Gruen et al. 1996).
Figure 5. Effects of intra-caudate administration of muscimol and saline on the baseline discrimination and reversal phases of the task per subject. Baseline discrimi-
nation phase performance is displayed as bar graphs with the total number of responses in the baseline discrimination phase, split into correct (light shading) and
incorrect trials/errors (dark shading). Reversal phase performance is shown as a learning curve, with cumulative errors plotted against trials. F denotes the failure of
a subject to pass the relevant phase at a speciﬁc dose.
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A key advantage of the present design of the serial discrimina-
tion reversal paradigm is the daily baseline discrimination phase,
in which subjects are tested on the previous day’s response-
outcome contingencies. The baseline phase of the task serves as
a useful control during manipulations; if a subject can success-
fully discriminate between the stimuli in this baseline phase, any
deﬁcits seen in performance during the subsequent reversal
phase can be assumed to be restricted to the special demands of
the reversal itself, and not due to difﬁculties in other domains
such as discriminative capability, attention, or motivation. Thus,
these effects on other domains cannot easily account for the
selective effects on reversal learning reported here following low
to intermediate doses of muscimol infused into the putamen and
caudate. Instead, it can be inferred that the putamen plays a
selective facilitatory role and the medial caudate an antagonistic
role, in ﬂexible, adaptive responding during serial reversal perfor-
mance. This conclusion is somewhat at odds with past ﬁndings
both from our laboratory and others in which disruptions of cau-
date function in the marmoset (and dorsomedial striatum in
rodents) impair reversal learning. However, it is broadly consis-
tent with the evidence from (Groman et al. 2013) in vervet mon-
keys and in humans with focal lesions of the basal ganglia, which
speciﬁcally affect the putamen (Bellebaum et al. 2008).
Deeper analysis of the reversal learning impairment after
intra-putamen muscimol indicated that animals were less
likely to stay with the newly rewarded stimulus immediately
after reversal. This may be consistent with an account whereby
the positive prediction error (win-stay) normally occurring
following unexpected reward is blunted after putamen inacti-
vation. However, the ﬁnding that a qualitatively similar (non-
signiﬁcant) reduction was apparent for lose-shift behavior
suggests a more general loss of reinforcement sensitivity.
In explaining the putamen reversal deﬁcit, it may also be
necessary to take into account the over-learned nature of rever-
sal learning in the present study. In previous marmoset and
rodent studies, the animals have been relatively naïve to rever-
sal learning, in marked contrast to the present study in which
marmosets had received extensive training prior to cannula-
tion. Such extensive training allowed for a stable baseline of
serial reversal performance and thus facilitated the comparison
of the effects of multiple doses of muscimol in the caudate and
putamen across sessions. However, by achieving that stable
baseline, animals’ responding may have undergone a shift
from goal-directed actions to habits (Adams and Dickinson
1981a, 1981b; DeRusso et al. 2010; Smith and Graybiel 2013).
Certainly, there is support in the literature for the formation of
reversal learning sets over successive reversal problems involv-
ing not only novel discriminative pairs (Harlow 1949; Meyer
1951) but also the same pair of stimuli (Warren 1966; Gaffan
and Harrison 1984; Gaffan 1985; Rygula et al. 2010; Jang et al.
2015). In particular, the development of learning sets has been
demonstrated in marmoset monkeys across discrimination
problems, reversal learning problems, and in serial reversal
learning as described here (Cotterman et al. 1956; Miles and
Meyer 1956; Rygula et al. 2010). That intra-putamen muscimol
infusions impaired reversal learning performance is consistent
with the proposal that this region of the striatum mediates
habitual responding in rodents (Packard and Knowlton 2002;
Graybiel 2008; Graybiel and Grafton 2015) and non-human pri-
mates (Fernandez-Ruiz et al. 2001; Miyachi et al. 1997, 2002;
Deffains et al. 2010; but see Desmurget and Turner 2010).
Whilst habitual control over behavior has been considered
primarily in the context of automatized stimulus-response asso-
ciations (Dickinson 1985), we suggest that the application of
well-learned rules of the form “if not A then B” (or “lose (A)—
shift (to B)”) may become similarly automatized. We have shown
previously that lesions of the ventrolateral prefrontal cortex, a
key region in learning and generalizing rules in marmosets (Dias
et al. 1996, 1997; Rygula et al. 2010) and humans (Bunge et al.
2003), only disrupt serial reversal learning when new stimuli are
introduced, whereas lesions of the anterior OFC impair reversal
learning regardless (Rygula et al. 2010). This suggests a different
circuit is involved in applying the same rule, i.e., if not A then
B, with novel visual stimuli, compared to familiar visual stimu-
li. We propose that the latter may be considered akin to an
abstract, but still automatic, form of behavioral control, which,
like simpler, more concrete stimulus-response associations, is
dependent upon circuitry including the putamen. Indeed, an
early study (Reading et al. 1991) showed that the acquisition of
a visual instrumental discrimination task, which could be con-
strued as an example of the application of a conditional rule to
stimulus-response learning, was impaired by lesions of the lat-
eral striatum (homologous to putamen) in rats. More recently,
(Seymour et al. 2007) reported that activity in the putamen in a
human fMRI study reﬂected negative prediction errors in rein-
forcement learning which may underpin the application of “A
not B” (or “lose-shift”) rules.
The dependence on the putamen for successful serial rever-
sal learning is in marked contrast to the apparent antagonistic
role of the medial caudate nucleus, as reﬂected in improved
reversal learning following low-dose intra-caudate muscimol.
Unlike the putamen, the caudate has been implicated in ﬂexi-
ble goal-directed behavior in rats (Kirkby 1969; Ragozzino et al.
2002; Castañé et al. 2010), monkeys (Divac et al. 1967; Clarke
et al. 2008), and humans (Rogers et al. 2000; Cools et al. 2002),
and a number of studies has shown the deleterious impact that
the goal-directed and habit systems may have on one another
if their balance is dysregulated. Such imbalances have been
postulated and reported in a number of psychiatric disorders,
including OCD and drug addiction (Gillan and Robbins 2014;
Voon et al. 2015; Ersche et al. 2016). Thus, when a task is well-
learned and controlled predominantly by the habit system,
activation of the goal-directed system may become counter-
productive, attempting to unnecessarily widen the search
space for alternative responses following an error. Consequently,
low-dose intra-caudate muscimol may facilitate control by the
habit system through inhibition of the goal-directed system. This
hypothesis is supported by the nearly signiﬁcant increase in
lose-shift responding that underpins the low-dose intra-caudate
reversal improvement.
In contrast, the more general impairment in discrimination
performance across both baseline and reversal phases pro-
duced by higher dose, as compared to lower dose, intra-
caudate muscimol, may have arisen from a more potent or
widespread inactivation. This generalized deﬁcit is unlikely to
have been due to impaired visual discrimination learning,
since previously we have shown that lesions of the medial
caudate nucleus, including the region targeted in the present
study, did not impair the acquisition of a visual discrimination
involving novel stimuli (Clarke et al. 2008). Such visual dis-
crimination impairments have been associated with connec-
tions between visual association cortex and the tail of the
caudate (Middleton and Strick 1996; Kim and Hikosaka 2015).
Thus instead, the generalized deﬁcit seen in the present study
may have been due to other difﬁculties, such as identifying
the currently rewarded stimulus in a context of high interfer-
ence as a consequence of both stimuli having been rewarded
on multiple previous occasions.
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In terms of limitations of the present study, the order of infu-
sions were not counterbalanced between sites, but it is difﬁcult
to envisage how this may have contributed to the pattern of
results obtained. Certainly, baseline performance remained sta-
ble across the study. An additional limitation is on interpretation
of the nature of the speciﬁc impact of different doses of musci-
mol on striatal output. At high enough doses the overall effect of
muscimol will be to silence striatal output (e.g., Yin et al. 2006;
Schilman et al. 2010; Bissonette and Roesch 2015). However, little
is known about the relative sensitivity of, e.g., medium spiny
output neurons versus various populations of interneurons
within the striatum to GABA agonists. Thus, the paradoxical
facilitatory effect of low-dose intra-caudate muscimol may
therefore have arisen via release of medium spiny neurons from
inhibition through GABA agonist-mediated hyperpolarization of
inhibitory striatal interneurons. Alternatively, depolarization of
striatal cholinergic interneurons (Login et al. 1998) may have
affected performance through the release of acetylcholine onto
muscarinic cholinergic receptors (Ragozzino et al. 2002). Finally,
whilst infusions were targeted to sub-regions of the caudate and
putamen that have previously been implicated in reversal learn-
ing, both in marmosets and other non-human primates, the pos-
sibility that other microcircuits within either area would be
differentially affected cannot be ruled out.
In summary, the present study has provided causal evidence
for a speciﬁc contribution of the putamen in serial reversal
learning performance. Patients with neurological disorders such
as Parkinson’s (Swainson et al. 2000) and Huntington’s diseases
(Lange et al. 1995) or with focal lesions (Bellebaum et al. 2008)
affecting the dorsal striatum, as well as neuropsychiatric disor-
ders such as schizophrenia (Leeson et al. 2009) and OCD
(Remijnse et al. 2005), have all been shown to exhibit simple
visual reversal deﬁcits under certain conditions, although it is
less clear that the latter implicate the putamen speciﬁcally. The
present report complements the growing literature highlighting
the importance of the putamen in the control of well-learned
stimulus-response habits, by extending its role to other, higher-
order forms of automatic control whereby a simple conditional
rule of the form “if not A, then B”, can be used to guide selection
from a pool of over-trained stimulus–response associations (in
this case, two). Such a role may for example, be important in
explaining higher-order deﬁcits in cognition in OCD patients
recently shown to exhibit reduced functional connectivity
between the dorsolateral prefrontal cortex and putamen in rela-
tion to cognitive performance (Vaghi et al. 2017).
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Supplementary material is available at Cerebral Cortex online.
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